chromadex.comHome - ChromaDex

chromadex.com Profile

chromadex.com is a domain that was created on 1999-07-30,making it 25 years ago. It has several subdomains, such as investors.chromadex.com extranet.chromadex.com , among others.

Description:A global bioscience company dedicated to healthy aging. Pioneering research on nicotinamide adenine dinucleotide...

Discover chromadex.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

chromadex.com Information

HomePage size: 43.612 KB
Page Load Time: 0.676898 Seconds
Website IP Address: 172.67.23.12

chromadex.com Similar Website

ChromaDex - Leading Provider of Phytochemical Reference Standards
extranet.chromadex.com

chromadex.com PopUrls

ChromaDex: Home
https://www.chromadex.com/
PHYSCION
https://standards.chromadex.com/PHYSCION
INDIGO(RG) - 100mg
https://standards.chromadex.com/INDIGO
ALLICIN (In Solution)
https://beta.chromadex.com/ALLICIN
CINCHONIDINE
https://standards.chromadex.com/CINCHONIDINE
BRUCINE(RG)
https://beta.chromadex.com/BRUCINE
NEOLINUSTATIN
https://standards.chromadex.com/NEOLINUSTATIN
CHARANTIN(P) - 5mg
https://standards.chromadex.com/CHARANTIN
DIHYDROKAVAIN
https://beta.chromadex.com/DIHYDROKAVAIN
Home | ChromaDex
https://standards.chromadex.com/
Standards - ChromaDex
https://www.chromadex.com/standards-overview/
About - ChromaDex
https://www.chromadex.com/about-us/
ChromaDex Corp. - ChromaDex Shares Findings from First-Ever Peer ...
https://investors.chromadex.com/news/news-details/2022/ChromaDex-Shares-Findings-from-First-Ever-Peer-Reviewed-Published-Clinical-Study-Analyzing-the-
ChromaDex Corp. - ChromaDex Announces Results of New Pilot Clinical ...
https://investors.chromadex.com/news/news-details/2022/ChromaDex-Announces-Results-of-New-Pilot-Clinical-Trial-Showing-Anti-Inflammatory-Effects-of-Ni
ChromaDex Reports FDA's Conclusion that Nicotinamide Mononucleotide ...
https://investors.chromadex.com/news/news-details/2022/ChromaDex-Reports-FDAs-Conclusion-that-Nicotinamide-Mononucleotide-NMN-May-Not-Be-Sold-or-Marke

chromadex.com DNS

A chromadex.com. 300 IN A 104.22.12.160
AAAA chromadex.com. 300 IN AAAA 2606:4700:10::ac43:170c
MX chromadex.com. 300 IN MX 0 mx1-us1.ppe-hosted.com.
NS chromadex.com. 21600 IN NS chin.ns.cloudflare.com.
TXT chromadex.com. 300 IN TXT EDE1CB0400
SOA chromadex.com. 1800 IN SOA chin.ns.cloudflare.com. dns.cloudflare.com. 2340635204 10000 2400 604800 1800

chromadex.com Httpheader

Date: Tue, 14 May 2024 19:53:59 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
x-pingback: https://www.chromadex.com/xmlrpc.php
link: https://www.chromadex.com/wp-json/; rel="https://api.w.org/", https://www.chromadex.com/wp-json/wp/v2/pages/2; rel="alternate"; type="application/json", https://www.chromadex.com/; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
x-cache: HIT: 9
x-cache-group: normal
CF-Cache-Status: DYNAMIC
Strict-Transport-Security: max-age=15552000; preload
X-Content-Type-Options: nosniff
Server: cloudflare
CF-RAY: 883d70010c870842-IAD

chromadex.com Meta Info

charset="utf-8"/
content="ie=edge" http-equiv="x-ua-compatible"/
content="width=device-width, initial-scale=1.0" name="viewport"/
content="max-image-preview:large" name="robots"
content="en_US" property="og:locale"
content="website" property="og:type"
content="Home - ChromaDex" property="og:title"/
content="A global bioscience company dedicated to healthy aging. Pioneering research on nicotinamide adenine dinucleotide (NAD+)." property="og:description"/
content="https://www.chromadex.com/" property="og:url"/
content="ChromaDex" property="og:site_name"/
content="https://www.chromadex.com/wp-content/uploads/2018/10/bg-img-1.jpg" property="og:image"/
content="https://www.chromadex.com/wp-content/uploads/2018/10/bg-img-1.jpg" property="og:image:secure_url"/
content="1024" property="og:image:width"/
content="410" property="og:image:height"/
content="summary_large_image" name="twitter:card"/
content="A global bioscience company dedicated to healthy aging. Pioneering research on nicotinamide adenine dinucleotide (NAD+)." name="twitter:description"/
content="Home - ChromaDex" name="twitter:title"/
content="@Chromadex" name="twitter:site"/
content="https://www.chromadex.com/wp-content/uploads/2018/10/bg-img-1.jpg" name="twitter:image"/
content="@Chromadex" name="twitter:creator"/
content="a0fcfb03a5c997404dc776ade4793d4a" name="msvalidate.01"/
content="bOpCYbV8GVtB0kbBNb4m2aobOjWI0WsW5sKJHvbo71g" name="google-site-verification"/

chromadex.com Html To Plain Text

Click to view our accessibility statement or contact us with accessibility-related questions Menu Close About About Leadership Science Contact Scientific Advisory Board Management TRU NIAGEN Ingredients Ingredients overview NIAGEN IMMULINA Patents Standards Research Overview Apply CERP Publications Newsletters Investor Relations News A global bioscience company dedicated to healthy aging. Pioneering research on nicotinamide adenine dinucleotide (NAD+) . Our Flagship Product TRU NIAGEN® Helping the World Age Better® Our team of scientists discovered that nicotinamide riboside (NR) could increase levels of NAD+, a vital function in cellular health that supports healthy aging. We then licensed patents for the nutritional and therapeutic uses of the breakthrough ingredient. Commercialized as Niagen®, it has been validated by extensive clinical research to be safe and effective at boosting NAD + levels. We deliver Niagen® as the sole active ingredient in our consumer product Tru Niagen®. Learn More About Tru Niagen Gold-Standard Services Reference Standards We are a leading provider of phytochemical reference standards, botanical reference materials, and research-grade materials for the natural products industry. We now list over 1800 phytochemicals and 400 botanical reference materials in our catalog. Learn More About Reference Standards Innovative Ingredients We leverage our complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies. Our portfolio of patented ingredient technologies includes: Niagen® nicotinamide riboside; IMMULINA™, a spirulina extract; and AnthOrigin™, anthocyanins derived from a domestically-produced, water-extracted purple corn. Learn More About Innovative Ingredients Investor Relations We leverage our complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. Learn More About Investor Relations Company About Investor Relations Press Releases Careers Customer Service Login Contact Legal Patents Privacy Policy California Consumer Privacy Statement Terms of Use Ethics and Compliance Subscribe to Our Newsletter [mailpoet_form ] By clicking sign up,” you agree to receive emails from ChromaDex and accept our terms of use, privacy and cookies policy.*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. © 2024 ChromaDex ,...

chromadex.com Whois

Domain Name: CHROMADEX.COM Registry Domain ID: 8637678_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-09-03T17:17:48Z Creation Date: 1999-07-30T16:57:22Z Registry Expiry Date: 2025-11-01T10:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: CHIN.NS.CLOUDFLARE.COM Name Server: DEREK.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T13:31:00Z <<<